Publication:
Molecular assays for antimalarial drug resistance surveillance: A target product profile

dc.contributor.authorChristian Nsanzabanaen_US
dc.contributor.authorFrederic Arieyen_US
dc.contributor.authorHans Peter Becken_US
dc.contributor.authorXavier C. Dingen_US
dc.contributor.authorEdwin Kamauen_US
dc.contributor.authorSanjeev Krishnaen_US
dc.contributor.authorEric Legranden_US
dc.contributor.authorNaomi Lucchien_US
dc.contributor.authorOlivo Miottoen_US
dc.contributor.authorSidsel Nagen_US
dc.contributor.authorHarald Noedlen_US
dc.contributor.authorCally Roperen_US
dc.contributor.authorPhilip J. Rosenthalen_US
dc.contributor.authorHenk D.F.H. Schalligen_US
dc.contributor.authorSteve M. Tayloren_US
dc.contributor.authorSarah K. Volkmanen_US
dc.contributor.authorIveth J. Gonzalezen_US
dc.contributor.otherDuke University Medical Centeren_US
dc.contributor.otherMedizinische Universitat Wien, Zentrum für Pathophysiologie, Infektiologie und Immunologieen_US
dc.contributor.otherFoundation for Innovative New Diagnostics, Switzerlanden_US
dc.contributor.otherHarvard School of Public Healthen_US
dc.contributor.otherLondon School of Hygiene & Tropical Medicineen_US
dc.contributor.otherKøbenhavns Universiteten_US
dc.contributor.otherSt George's University of Londonen_US
dc.contributor.otherUniversite Paris Descartesen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherUniversity of California, San Franciscoen_US
dc.contributor.otherUniversitat Baselen_US
dc.contributor.otherSwiss Tropical and Public Health Institute (Swiss TPH)en_US
dc.contributor.otherCenters for Disease Control and Preventionen_US
dc.contributor.otherHopital Cochin AP-HPen_US
dc.contributor.otherCopenhagen University Hospitalen_US
dc.contributor.otherWalter Reed Army Institute of Researchen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUnited States Armyen_US
dc.contributor.otherWellcome Sanger Instituteen_US
dc.contributor.otherUniversity of Amsterdamen_US
dc.contributor.otherInstitut Pasteur, Parisen_US
dc.contributor.otherBroad Instituteen_US
dc.contributor.otherSimmons Universityen_US
dc.date.accessioned2019-08-23T10:14:54Z
dc.date.available2019-08-23T10:14:54Z
dc.date.issued2018-09-01en_US
dc.description.abstractThis is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. Antimalarial drug resistance is a major constraint for malaria control and elimination efforts. Artemisinin-based combination therapy is now the mainstay for malaria treatment. However, delayed parasite clearance following treatment with artemisinin derivatives has now spread in the Greater Mekong Sub region and may emerge or spread to other malaria endemic regions. This spread is of great concern for malaria control programmes, as no alternatives to artemisinin-based combination therapies are expected to be available in the near future. There is a need to strengthen surveillance systems for early detection and response to the antimalarial drug resistance threat. Current surveillance is mainly done through therapeutic efficacy studies; however these studies are complex and both time- and resource-intensive. For multiple common antimalarials, parasite drug resistance has been correlated with specific genetic mutations, and the molecular markers associated with antimalarial drug resistance offer a simple and powerful tool to monitor the emergence and spread of resistant parasites. Different techniques to analyse molecular markers associated with antimalarial drug resistance are available, each with advantages and disadvantages. However, procedures are not adequately harmonized to facilitate comparisons between sites. Here we describe the target product profiles for tests to analyse molecular markers associated with antimalarial drug resistance, discuss how use of current techniques can be standardised, and identify the requirements for an ideal product that would allow malaria endemic countries to provide useful spatial and temporal information on the spread of resistance.en_US
dc.identifier.citationPLoS ONE. Vol.13, No.9 (2018)en_US
dc.identifier.doi10.1371/journal.pone.0204347en_US
dc.identifier.issn19326203en_US
dc.identifier.other2-s2.0-85053676487en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/44690
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053676487&origin=inwarden_US
dc.subjectAgricultural and Biological Sciencesen_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleMolecular assays for antimalarial drug resistance surveillance: A target product profileen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053676487&origin=inwarden_US

Files

Collections